Article
Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension
27 Sept 2023
Abstract excerpt
Pulmonary arterial hypertension (PAH) comprises a heterogeneous group of diseases with diverse aetiologies. It is characterized by increased pulmonary arterial pressure and right ventricular (RV) failure without specific drugs for treatment. Emerging evidence suggests that inflammation and autoimmune disorders are common features across all PAH phenotypes. This provides a novel idea to explore the characteristics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
